The benefits of breast cancer screening are vastly overestimated as the figures do not back them up in practice, scientists who conducted an in-depth review of principal trials have said. The team looked at studies on screening for breast, colorectal, cervical, prostate and lung cancers that were started in Sweden in the 1960s and 70s.

Click here to read original article